Patents by Inventor Istvan Horvath
Istvan Horvath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11845758Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.Type: GrantFiled: June 30, 2023Date of Patent: December 19, 2023Assignees: PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT., EÖTVÖS LORÁND TUDOMÁNYEGYETEMInventors: András Málnási-Csizmadia, Máté Gyimesi, András Szabó, Péter Hári, Suthar Sharad Kumar, Mihály Kovács, Ádám István Horváth, Máté Pénzes, István Lörincz, László Végner, Zoltán Simon, Sándor Bátori, Zoltán Szönyegi, Vajik Horváth, József Répási
-
Publication number: 20230339959Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.Type: ApplicationFiled: June 30, 2023Publication date: October 26, 2023Inventors: András MÁLNÁSI-CSIZMADIA, Máté GYIMESI, András SZABÓ, Péter HÁRI, Suthar Sharad KUMAR, Mihály KOVÁCS, Ádám István HORVÁTH, Máté PÉNZES, István LORINCZ, László VÉGNER, Zoltán SIMON, Sándor BÁTORI, Zoltán SZONYEGI, Vajik HORVÁTH, József RÉPÁSI
-
Patent number: 11746112Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.Type: GrantFiled: April 18, 2019Date of Patent: September 5, 2023Assignees: EÖTVÖS LORÁND TUDOMÁNYEGYETEM, PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT.Inventors: András Málnási-Csizmadia, Maté Gyimesi, András Szabó, Péter Hári, Suthar Sharad Kumar, Mihály Kovács, Ádám István Horváth, Máté Pénzes, István Lörincz, László Végner, Zoltán Simon, Sándor Bátori, Zoltán Szönyegi, Vajk Horváth, József Répási
-
Patent number: 11580856Abstract: A device can receive parking metadata that includes location data indicating that a portion of a vehicle is located outside of a designated parking area (DPA). The device can process the parking metadata to identify values that are to be used when determining actions to perform. The device can obtain supplemental events data associated with events occurring near the DPA. The device can determine the actions to perform based on the parking metadata and the supplemental events data. The device can provide, as one of the actions and to one or more other devices or to the vehicle, a message indicating that the portion of the vehicle is located outside of the DPA. This can cause the one or more other devices or the vehicle to: move the vehicle from the DPA, reposition the vehicle within the DPA, or penalize an owner of the vehicle.Type: GrantFiled: November 5, 2021Date of Patent: February 14, 2023Assignee: Verizon Patent and Licensing Inc.Inventors: Brian Refsdal, Nick G. Suizo, Kent Ryhorchuk, Tibor Gyimesi, Andrew W. Herson, Istvan Horvath
-
Publication number: 20220058946Abstract: A device can receive parking metadata that includes location data indicating that a portion of a vehicle is located outside of a designated parking area (DPA). The device can process the parking metadata to identify values that are to be used when determining actions to perform. The device can obtain supplemental events data associated with events occurring near the DPA. The device can determine the actions to perform based on the parking metadata and the supplemental events data. The device can provide, as one of the actions and to one or more other devices or to the vehicle, a message indicating that the portion of the vehicle is located outside of the DPA. This can cause the one or more other devices or the vehicle to: move the vehicle from the DPA, reposition the vehicle within the DPA, or penalize an owner of the vehicle.Type: ApplicationFiled: November 5, 2021Publication date: February 24, 2022Applicant: Verizon Patent and Licensing Inc.Inventors: Brian REFSDAL, Nick G. SUIZO, Kent RYHORCHUK, Tibor GYIMESI, Andrew W. HERSON, Istvan HORVATH
-
Patent number: 11176824Abstract: A device can receive parking metadata that includes location data indicating that a portion of a vehicle is located outside of a designated parking area (DPA). The device can process the parking metadata to identify values that are to be used when determining actions to perform. The device can obtain supplemental events data associated with events occurring near the DPA. The device can determine the actions to perform based on the parking metadata and the supplemental events data. The device can provide, as one of the actions and to one or more other devices or to the vehicle, a message indicating that the portion of the vehicle is located outside of the DPA. This can cause the one or more other devices or the vehicle to: move the vehicle from the DPA, reposition the vehicle within the DPA, or penalize an owner of the vehicle.Type: GrantFiled: December 18, 2018Date of Patent: November 16, 2021Assignee: Verizon Patent and Licensing Inc.Inventors: Brian Refsdal, Nick G. Suizo, Kent Ryhorchuk, Tibor Gyimesi, Andrew W. Herson, Istvan Horvath
-
Publication number: 20210251543Abstract: A system, devices, and methods are described for imaging and measuring the mechanical properties of both surface and subcutaneous tissues found in living organisms, animals, and in natural and synthetic materials, and may include a first device configured to determine a modulus of a portion of bulk material or subcutaneous tissue (via measurement of vibrations), and/or determine resonant frequency of the vibrations, and a second device operably connected to the first device and configured to generate vibrations. The first device may be an optical coherence tomography device. The system may include a processor and data storage device with instructions which when executed by the processor, cause the processor to process of the frequency data and the displacement data to determine a resonant frequency of the material under investigation and calculate the mechanical modulus of elasticity of the material from a resonance frequency spectrum of the analyzed spectral image.Type: ApplicationFiled: February 19, 2021Publication date: August 19, 2021Inventors: Frederick Howard Silver, Istvan Horvath, Nikita Uday Kelkar, Tanmay Manoj Deshmukh, Ruchit Girishchandra Shah
-
Publication number: 20210087201Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.Type: ApplicationFiled: April 18, 2019Publication date: March 25, 2021Inventors: András MÁLNÁSI-CSIZMADIA, Máté GYIMESI, András SZABÓ, Péter HÁRI, Suthar Sharad KUMAR, Mihály KOVÁCS, Ádám István HORVÁTH, Máté PÉNZES, István LORINCZ, László VÉGNER, Zoltán SIMON, Sándor BÁTORI, Zoltán SZONYEGI, Vajk HORVÁTH, József RÉPÁSI
-
Publication number: 20200193827Abstract: A device can receive parking metadata that includes location data indicating that a portion of a vehicle is located outside of a designated parking area (DPA). The device can process the parking metadata to identify values that are to be used when determining actions to perform. The device can obtain supplemental events data associated with events occurring near the DPA. The device can determine the actions to perform based on the parking metadata and the supplemental events data. The device can provide, as one of the actions and to one or more other devices or to the vehicle, a message indicating that the portion of the vehicle is located outside of the DPA. This can cause the one or more other devices or the vehicle to: move the vehicle from the DPA, reposition the vehicle within the DPA, or penalize an owner of the vehicle.Type: ApplicationFiled: December 18, 2018Publication date: June 18, 2020Inventors: Brian REFSDAL, Nick G. SUIZO, Kent RYHORCHUK, Tibor GYIMESI, Andrew W. HERSON, Istvan HORVATH
-
Patent number: 9407573Abstract: This application discloses a controller area network (CAN) design and verification tool to identify periodic messages and sporadic messages that a control node is configured to transmit on a shared bus in a CAN design. The CAN design and verification tool can assign placeholders to a schedule table of the control node to define a message transmission schedule for the control node. The placeholders include at least one sporadic message placeholder configured to identify one of a plurality of minor time frames available on the shared bus for the control node to transmit any one of the sporadic messages. The CAN design and verification tool can determine a worst-case latency associated with delivery of a first one of the sporadic messages on the shared bus when the control node utilized the sporadic message placeholder to transmit a second one of the sporadic messages on the shared bus.Type: GrantFiled: August 29, 2013Date of Patent: August 2, 2016Assignee: Mentor Graphics CorporationInventors: Istvan Horvath, Zoltan Matyas
-
Patent number: 9294412Abstract: This application discloses determining a worst-case latency in a controller area network (CAN) for messages experiencing priority inversion within individual controllers. A system to determine the worst-case latency can include a memory system to store computer-executable instructions and a computing system, in response to execution of the computer-executable instructions, can identify that a controller area network (CAN) design includes a controller configured to sequence messages for transmission over a shared bus with at least one of the messages experiencing priority inversion. The computing system also can determine a delay for the controller to present a first message to the shared bus for transmission when the first message is ordered behind a second message having a lower priority than the first message. The delay may be a portion of the worst-case latency corresponding to the priority inversion.Type: GrantFiled: August 29, 2013Date of Patent: March 22, 2016Inventors: Istvan Horvath, Zoltan Matyas
-
Publication number: 20150063120Abstract: This application discloses determining a worst-case latency in a controller area network (CAN) for messages experiencing priority inversion within individual controllers. A system to determine the worst-case latency can include a memory system to store computer-executable instructions and a computing system, in response to execution of the computer-executable instructions, can identify that a controller area network (CAN) design includes a controller configured to sequence messages for transmission over a shared bus with at least one of the messages experiencing priority inversion. The computing system also can determine a delay for the controller to present a first message to the shared bus for transmission when the first message is ordered behind a second message having a lower priority than the first message. The delay may be a portion of the worst-case latency corresponding to the priority inversion.Type: ApplicationFiled: August 29, 2013Publication date: March 5, 2015Inventors: Istvan Horvath, Zoltan Matyas
-
Publication number: 20150063371Abstract: This application discloses a controller area network (CAN) design and verification tool to identify periodic messages and sporadic messages that a control node is configured to transmit on a shared bus in a CAN design. The CAN design and verification tool can assign placeholders to a schedule table of the control node to define a message transmission schedule for the control node. The placeholders include at least one sporadic message placeholder configured to identify one of a plurality of minor time frames available on the shared bus for the control node to transmit any one of the sporadic messages. The CAN design and verification tool can determine a worst-case latency associated with delivery of a first one of the sporadic messages on the shared bus when the control node utilized the sporadic message placeholder to transmit a second one of the sporadic messages on the shared bus.Type: ApplicationFiled: August 29, 2013Publication date: March 5, 2015Inventors: Istvan Horvath, Zoltan Matyas
-
Patent number: 6598107Abstract: The present invention relates to a method of communicating data between at least two units (1) on a serial bus (2) in a car, wherein the units 11) have independent clocks, the data being transmitted as a sequence (3) of frames (4), each frame including an identifier field (9) and a data field (10). In order to ensure an always reliable and synchronized communication of data on a serial bus with different types of units (clocks) where randomly distributed periods of idle time may occur on the bus it is suggested that prior to any sequence (3) of frames (4), a signal pattern (7) is transmitted on the bus (2), so as to set the bus to a definite state for a predetermined period of time.Type: GrantFiled: May 4, 2000Date of Patent: July 22, 2003Assignees: Motorola, Inc., Volcano Communications Technologies, ABInventors: Hans Christian von der Wense, István Horváth, Antal Rajnák
-
Patent number: 4544740Abstract: The invention relates to (E)-5-(2-bromovinyl)-uridine and its derivatives of general formula VI, ##STR1## wherein R.sup.1 stands for a hydrogen atom, C.sub.1-8 alkanoyl group, benzoyl group or a benzoyl group substituted in para position either with a C.sub.1-4 alkyl group or a halogen atom, and a process for preparing them by brominating 2',3',5'-tri-O-acyl-5-ethyl-uridine of general formula IV, ##STR2## wherein R is identical with R.sup.1, except where R.sup.1 stands for a hydrogen atom, dehydrohalogenating the resulting dibromo compound of general formula V ##STR3## and optionally deacylating it. The resulting compounds of general formula VI are exhibiting significant potency against Herpes simplex virus species and are of remarkably low acute toxicity.Type: GrantFiled: September 7, 1982Date of Patent: October 1, 1985Assignee: Egyt Gyogyszervegyeszeti GyarInventors: Anna Szabolcs nee Borbas, Laszlo tvos, Janos Sagi, Attila Szemzo, Maria Peredy nee Kajtar, Istvan Horvath, Istvan Koczka, Csilla Rethati, Pal Ivan, Ildiko Fritzsche nee Lukacs, Janos Nagy
-
Patent number: 4537899Abstract: The invention relates to acylated 1,2,4-triazole derivatives of general formula I ##STR1## wherein R.sup.1 represents an unsubstituted phenyl group or a phenyl group substituted by one or more halogen atoms, lower alkyl, alkoxy, acyloxy, hydroxy, amino, azido, nitro, trifluoromethyl, lower alkylthio, alkylsulfinyl, or alkylsulfonyl group, andR.sup.2 stands for a C.sub.1-6 alkyl group or a phenyl lower alkyl group which is either unsubstituted or substituted in the aromatic nucleus by a halogen atom or a nitro group,and their pharmaceutically acceptable salts, and a process for preparing them. The new compounds according to the invention exhibit valuable antiviral activity.Type: GrantFiled: August 25, 1983Date of Patent: August 27, 1985Assignee: BIOGAL GyogyszergyarInventors: Istvan Horvath, Tibor Lang, Laszlo Pongo, Jozsef Reiter, Tamas Somorai, Geza Szilagyi, Lajos Toldy
-
Patent number: 4530964Abstract: The invention relates to new, pharmaceutically active copolymers with heparin-like activity, pharmaceutically acceptable salts thereof and a process for their preparation.Type: GrantFiled: March 24, 1983Date of Patent: July 23, 1985Assignee: Richter Gedeon Vegyeszeti Gyar R.T.Inventors: Raymund Machovich, Miklos Nagy, Judit Gyorgyi nee Edelenyi, Istvan Horvath, Miklos Low, Katalin Csomor, Egon Karpati, Laszlo Szporny, Lajos Kisfaludy
-
Patent number: 4456601Abstract: New .DELTA..sup.1,3,5 -3-chloro-pregnane derivatives of the general formula (I), ##STR1## wherein X is hydrogen atom, acetyl group or a chloroacetyl group, andY and Z represent hydrogen atom or a halogen atom, with the proviso that at least one of them is other than hydrogen,are prepared by reacting a .DELTA..sup.1,4 -3-oxo-pregnane derivative of the general formula (II), ##STR2## wherein X' is acetyl group or a chloroacetyl group and Y and Z are as defined above, with a chloromethyleneiminium salt of the general formula (III), ##STR3## wherein A.sup.(-) is a salt-forming anion, in an aprotic solvent in the presence of a tertiary base, and, if desired, subjecting the resulting product to hydrolysis.The compounds of the general formula (I) exert antiphlogistic effects and can be used in the therapy for the treatment of inflammations.Type: GrantFiled: October 14, 1982Date of Patent: June 26, 1984Assignee: Richter Gedeon Vegyeszeti Gyar Rt.Inventors: Jozsef Toth, Gyorgy Hajos, Gyorgy Fekete, Istvan Horvath, Laszlo Szporny, Anna Boor nee Mezei, Peter Aranyi, Aniko Naray, Sandor Gorog, Sandor Holly, Csaba Molnar
-
Patent number: 4396630Abstract: Adjuvant particles are prepared from lipoid-soluble substances, and compositions comprising the particles and biologically active substances adsorbed thereon are provided. The adjuvant systems are capable of binding a wide variety of biologically active substances, and can be used in vivo and in vitro as well.Type: GrantFiled: December 19, 1980Date of Patent: August 2, 1983Assignee: Human Oltoanyagtermelo es Kutato IntezetInventors: Zoltan Riedl, Laszlo Sztankov, Istvan Horvath
-
Patent number: D335885Type: GrantFiled: July 9, 1991Date of Patent: May 25, 1993Assignee: Timfold-es Mukorundgyar MagyarovariInventor: Istvan Horvath